Most Active Stocks as The Market Starts The New Year Off on a Bull run!
* Reuters is not responsible for the content in this press release.
For best results when printing this announcement, please click on the link below: http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130103:nPn1030774 NEW YORK, January 3, 2013 /PRNewswire/ -- Markets were seen soaring yesterday as a fiscal cliff deal was reached. The DOW closed up 300 points from the previous close as the NSADAQ saw gains of over 3%. Investors realized the importance of yesterday's deal and the markets saw a move that hasn't been seen in weeks. The Stock Freak has a team of well diverse market professionals that has combined experience of over 30 years that today are providing members with a quick research report on 5 companies. Pfizer Inc (NYSE:PFE) - There was a total of 10 Insider transactions on Dec 28th 2012. The Biggest Trade was from Chairman and CEO Ian Read who purchased 416 shares at a price per share of $24.89 for a total cost of $ 10,354.20 Whether bull or bear The Stock Freak has got you covered! Sign up to receive our free newsletters and stay up to date with stocks on the run. http://www.TheStockFreak.com Keycorp (NYSE:KEY) - On Dec 31st 2012 Kristen Manos Director of Keycorp bought 11,276 shares World Moto (OTC:FARE) World Moto has had a big volume week so far. The stock traded over 20 million shares yesterday and closed up 8% from the previous day's closing price. Amr Corp (OTC:AAMRQ) - American airlines although in Bankruptcy still continues to trade heavy volume. The stock traded over 5 million shares yesterday and closed the day up 8%. Amarantus Biosciences (OTC:AMBS) - AMBS had a massive day in volume yesterday trading nearly 10 million shares over its average daily volume. The stock closed up 30% for the first trading day in 2013. Amarantus BioSciences is a development-stage biotechnology company, focuses on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson's disease. To find similar research reports that are available for free follow the link below and sign up at http://www.TheStockFreak.com Disclosure: TheStockFreak.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. The Stock Freak is a wholly owned entity of a financial public relations firm. Please read our report and visit our website, for complete risks and disclosures. SOURCE www.thestockfreak.com Contact: Info@thestockfreak.com, 433 plaza real Suite 275, Boca Raton, Fl, 33432, +1-561-372-8342
- WTO overcomes last minute hitch to reach its first global trade deal
- Colorado baker discriminated by denying gay couple wedding cake: judge
- Flights delayed as air pollution hits record in Shanghai
- Amish girl in Ohio will not be forced to resume chemo for cancer
- South Africa mourns Mandela, will bury him on December 15 |